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Abstract
Aims: Chemotherapeutics target vital functions that ensure survival of cancer cells, including their increased reliance
on defense mechanisms against oxidative stress compared to normal cells. Many chemotherapeutics exploit this
vulnerability to oxidative stress by elevating the levels of intracellular reactive oxygen species (ROS). A quantitative
understanding of the oxidants generated and how they induce toxicity will be important for effective implementation
and design of future chemotherapeutics. Molecular tools that facilitate measurement and manipulation of individual
chemical species within the context of the larger intracellular redox network present a means to develop this
understanding. In this work, we demonstrate the use of such tools to elucidate the roles of H2O2 and glutathione
(GSH) in the toxicity mechanism of two ROS-based chemotherapeutics, piperlongumine and phenethyl iso-
thiocyanate. Results: Depletion of GSH as a result of treatment with these compounds is not an important part of the
toxicity mechanisms of these drugs and does not lead to an increase in the intracellular H2O2 level. Measuring
peroxiredoxin-2 (Prx-2) oxidation as evidence of increased H2O2, only piperlongumine treatment shows elevation and
it is GSH independent. Using a combination of a sensor (HyPer) along with a generator (D-amino acid oxidase) to
monitor and mimic the drug-induced H2O2 production, it is determined that H2O2 produced during piperlongumine
treatment acts synergistically with the compound to cause enhanced cysteine oxidation and subsequent toxicity. The
importance of H2O2 elevation in the mechanism of piperlongumine promotes a hypothesis of why certain cells, such
as A549, are more resistant to the drug than others. Innovation and Conclusion: The approach described herein sheds
new light on the previously proposed mechanism of these two ROS-based chemotherapeutics and advocates for the
use of both sensors and generators of specific oxidants to isolate their effects. Antioxid. Redox Signal. 24, 924–938.
Introduction
Reactive oxygen species (ROS) are formed as a by-product of many intracellular processes, promoting a
variety of cellular responses from growth and proliferation at
lower concentrations, to lethal lipid and DNA damage when
present in excess (14, 25, 26, 35). Mounting evidence sug-
gests that many types of cancer cells have increased levels of
ROS compared to their normal counterparts (28, 53). This
elevation in oxidants is the cumulative result of intrinsic
factors such as activation of oncogenes, aberrant metabolism,
and mitochondrial dysfunction, combined with extrinsic
factors such as inflammatory signals from nearby immune
cells, carcinogens, and growth factor signaling (28, 41, 53).
To combat the toxic effects of elevated oxidative stress, tu-
Innovation
The present work represents the first use of tools for
measuring and manipulating H2O2 and glutathione (GSH)
levels to perform a thorough analysis of the redox changes
following treatment of tumor cells with reactive oxygen
species (ROS)-based chemotherapeutics piperlongumine
and phenethyl isothiocyanate. The reported data indicate
that contrary to previous publications involving these
compounds, GSH depletion plays an insignificant role in
the toxicity mechanism. The study also demonstrates how
the combined used of sensors and generators for specific
oxidants, in this case H2O2, can yield a deeper mechanistic
insight into how a particular ROS generated as a result of
treatment with these compounds causes toxicity.
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mor cells often have higher levels of antioxidants and are
extremely reliant on these molecules for survival (13). Thus,
it is believed that targeting these antioxidant defenses to
raise the oxidative stress level above the toxicity threshold
might be a viable option for selectively eliminating tumor
cells while sparing normal cells (13, 41, 48). Many cancer
chemotherapeutics have been identified using this ROS-
manipulating principle.
Intracellular glutathione (GSH) is an example of a target of
ROS-based chemotherapeutics. Given the role of GSH in the
reduction of H2O2 and the oxidation of sulfhydryl group, it is
believed that GSH depletion will cause toxicity via accu-
mulation of H2O2 and oxidized proteins (6). It has been
previously suggested that electrophilic small molecules such
as buthionine sulfoximine (BSO), piperlongumine (PL), and
phenethyl isothiocyanate (PEITC) convey at least part of
their toxicity via this mechanism (9, 16, 39, 49, 51, 56), and
all of these drugs have been shown to be selectively toxic to
certain in vitro and in vivo tumor models (1, 5, 13, 39). In-
cubation of tumor cells with piperlongumine and PEITC re-
sults in depletion of GSH and elevation of fluorescence from
dichloro-dihydro-fluorescein diacetate (DCFH-DA), a cell
permeable dye that exhibits increasing fluorescence intensity
upon oxidation (9, 39, 49, 56). However, recent compre-
hensive studies involving a broader class of small molecules
suggest that the depletion of GSH is often insufficient to
induce death of tumor cells. In a study of six chemothera-
peutics that induced varying degrees of GSH depletion, Zhu
et al. showed no discernible correlation between GSH level
and cell growth inhibition (57). This is corroborated by Ad-
ams et al., who created a library of piperlongumine analogs,
many of which caused depletion of GSH but no cell toxicity
(2). In addition, both groups measured the DCFH signal from
cells treated with a variety of small molecules, including
several current chemotherapeutics and their analogs, and
found that while many small-molecule chemotherapeutics
cause an increase in the DCFH signal, a dose–response re-
lationship between fluorescence intensity and toxicity of the
compound was not evident (1). These reports are difficult to
reconcile with previous hypotheses regarding the mechanism
of these compounds, and more generally highlight a lack of
detailed understanding of ROS and how these drugs utilize
ROS to cause toxic effects.
One way to improve our understanding is to discontinue
thinking of ROS as a collective entity, but rather consider
them as distinct molecules that have unique lifetimes, reac-
tivity, and reaction kinetics with varying downstream targets.
DCFH is oxidized by a one-electron, free radical mechanism,
so it responds to several ROS, reactive nitrogen species
(RNS), and even radicals localized on protein residues.
Furthermore, since the molecule does not react directly with
nonradical species such as H2O2, the signal can be affected by
confounding variables such as availability of a metal catalyst.
Activities of antioxidants, oxygen tension, and exposure to
light are additional variables that impact the DCFH signal
and lead to artifacts (54). Advances in specific protein-based
probes for certain redox species, such as H2O2, have ad-
dressed these difficulties. These sensors are fusions of fluo-
rescent proteins with bacterial or yeast domains that have
natural selectivity for reaction with hydrogen peroxide (3,
17). Fusions are constructed such that reversible changes in
the spectrum of the fluorescent protein occur when hydrogen
peroxide oxidizes a cysteine of the microbial or yeast protein,
causing it to subsequently form a disulfide bond with a
neighboring cysteine (34). Two spectral features are affected,
with an excitation peak at one wavelength decreasing and an
excitation peak at a second wavelength increasing in a dose-
dependent manner upon stimulation with hydrogen peroxide.
The ability to examine the ratio of two spectral features, in
contrast with measuring changes in fluorescence intensity for
only one feature like DCFH, enables better intracellular
quantification of H2O2 (21, 30, 47). The creation of these
reversible, quantitative, oxidant-specific probes opens up
new avenues for detailed study of oxidative stress produced
by chemotherapeutics.
Complementary to these measurement probes, tools that
allow determination of whether the observed level of anti-
oxidant depletion or oxidant production is important to the
toxicity of a drug, or merely a secondary effect of the com-
pound. This involves manipulating the antioxidant level
through reaction with small molecules and genetic over-
expression of protein generators that can produce specific
oxidants at controlled rates intracellularly. D-amino acid
oxidase (DAAO) from Rhodotorula gracilis has been previ-
ously shown to be a powerful intracellular enzyme that can
produce tunable and localizable H2O2 intracellularly de-
pending on the concentration of D-alanine (D-Ala) substrate
added (18, 20, 33). Using DAAO to provide spatial and
temporal control over the production of H2O2, we can mimic
the generation of the oxidant by chemotherapeutics and iso-
late its contribution to the mechanism of toxicity, if any.
In this study, we illustrate how using specific tools to
quantitatively measure and manipulate intracellular GSH and
H2O2 can contribute to a refined understanding of the in-
volvement of these species in the action of chemotherapeu-
tics, specifically piperlongumine and PEITC. We parse the
importance of GSH depletion in these compounds using
BSO, a specific GSH synthesis inhibitor. We also use a
combination of a specific H2O2 sensor, HyPer, with an in-
tracellular peroxide generator, DAAO, to determine if GSH
depletion is linked to H2O2 elevation, and if the amount of
H2O2 elevation is a critical part of drug toxicity. The resulting
insights allow us formulate a hypothesis about the bio-
chemical differences that contribute to the differential drug
responses of HeLa and A549 cells to these drugs. Then, using
nuclear factor erythroid 2-related factor 2 (Nrf-2) and Keap-1
knockout variants of a lung tumor model cell line, p53fl/
KrasG12D, we established a genetic cause of these biochem-
ical differences (10, 12). Our investigation illustrates the
value of using chemically specific sensing and perturbation
tools to gain a deeper understanding of ROS-based drugs,
whichmay translate to further success in designing additional
members of this class of promising therapeutic and to
matching drugs with tumors that are likely to be susceptible.
Results
Differential response of HeLa and A549
cells to piperlongumine and PEITC
We exposed HeLa and A549 cells to increasing concen-
trations of piperlongumine and PEITC for a period of 48 h.
We measured the inhibitory effects of the compounds by
counting the live cells remaining on the dish after a period of
48 h and comparing the result to that of a control culture
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exposed to the same amount of dimethyl sulfoxide (DMSO)
without a drug. We found that for both compounds, the A549
cells were more resistant than the HeLa cells. In the case
of piperlongumine, the concentration needed to inhibit the tu-
mor cell population by 50% was 4.4– 0.1lM for HeLa and
11.7– 2.0lM for A549; for PEITC it was 5– 0.08lM and
10.2– 1.1lM, respectively (Fig. 1). Comparing the toxicity of
the drug to both cell lines with toxicity to a nontumor forming
cell line, MCF-10A, the A549 cells were of similar resistance
while the HeLa cells were much more susceptible (Supple-
mentary Fig. S1; Supplementary Data are available online at
www.liebertpub.com/ars). The lack of selective toxicity for
A549 versus the nontumor cells suggests piperlongumine and
PEITC cannot be used effectively against these tumor cells,
while they can be used effectively against HeLa cells. We
investigated the potential role of GSH and H2O2 in the toxicity
mechanism of these drugs to formulate a hypothesis regarding
the biochemical differences between HeLa and A549 cells that
contribute to their differential responses.
The role of glutathione in piperlongumine
and PEITC mediated tumor inhibition
One of the mechanisms of piperlongumine and PEITC
toxicity suggested by previous studies is the depletion of the
total GSH level and the subsequent increase in oxidative
stress (5, 9, 39, 49, 56). We used a specific, small-molecule
inhibitor of GSH synthesis, BSO, as a control for determining
whether the level of depletion in the two compounds is an
important contributor to tumor inhibition (57). We found that
BSO did not cause significant growth inhibition in either the
HeLa or the A549 cell lines after 48 h (Fig. 2a). To measure
FIG. 1. Growth inhibition curves of PL and PEITC for HeLa and A549 cells. 1.5 · 105 cells were seeded in 12-well
dishes. After 24 h, PL and PEITC concentrations from 0 to15 lM were added and incubated for 48 h. Cells remaining on the
dish were counted and compared to the DMSO control after 48 h. Every curve contains three biological replicates, two
technical replicates each. Each point on the curve represents mean –95% confidence intervals. DMSO, dimethyl sulfoxide;
PEITC, phenethyl isothiocyanate; PL, piperlongumine.
FIG. 2. Toxicity and glutathione depletion effects of PL, PEITC, and BSO. (A) Incubation of HeLa and A549 cells
with BSO concentrations from 0 to 100lM. Cells remaining after 48 h were counted and compared to control cultures that
did not receive the drug. BSO did not induce toxicity in either cell line at the tested concentrations. Every curve contains
two biological replicates, two technical replicates each. Each point on the growth curve represents mean –95% confidence
intervals. (B) Measurement of total GSH concentration in the cell lysate. Cells were incubated with 10 lM PL, 10lM
PEITC, or 100lM BSO for a period of 10 h, then lysed, and total glutathione level was measured and normalized to the
amount of cell lysate. Cells incubated with BSO showed the most depletion in GSH level. A549 cells show the least
depletion of GSH in response to the drugs. Every condition has three biological replicates and two technical replicates each,
bar graph represents mean – standard deviation. *p < 0.05, **p < 0.01. BSO, buthionine sulfoximine; GSH, glutathione.
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the magnitude of GSH depletion, we quantified the intracel-
lular level of GSH in both cell lines after 10 h of exposure to
BSO, piperlongumine, and PEITC. HeLa cells exhibited a
twofold decrease in the level of GSH in response to PEITC,
and a fourfold decrease in response to piperlongumine. BSO
depleted the intracellular GSH level more significantly than
PEITC and to the same level as piperlongumine in these cell
lines (Fig. 2b). Together, these findings suggest that the de-
pletion of GSH alone is not enough to induce toxicity in HeLa
cells to the same degree as piperlongumine and PEITC. By
comparison, the A549 cells showed virtually no GSH de-
pletion effects as a result of treatment with piperlongumine or
PEITC.
The data in Figure 2 raise the question of whether the
resistance of A549 cells to GSH depletion contributes to the
overall resistance of these cells to piperlongumine and
PEITC in comparison with HeLa cells. One hypothesis is that
while GSH depletion might not be the main toxicity mech-
anism, the presence of additional GSH in the A549 cells
serves an important protective function. For example, if the
drug acted by causing damaging DNA modifications, cell
types with more GSH and more resistance to GSH depletion
by the drug would have greater capacity to repair the damage,
conferring resistance for the cell. We tested this hypothesis
by cotreating A549 cells with BSO and piperlongumine, or
BSO and PEITC, then comparing the subsequent GSH con-
centration and growth inhibition effects to those of HeLa
cells incubated with just piperlongumine or PEITC. The
purpose of the coincubation with BSO is to deplete the excess
GSH of the A549 cells to test the antioxidant’s protective
function against the drugs. Coincubating A549s with 75lM
of BSO and piperlongumine or PEITC depleted A549s’ GSH
level to 2% of the original concentration, well below the GSH
levels of HeLa cells treated with piperlongumine or PEITC
alone (Fig. 3a). However, the coincubation did not make the
A549s more susceptible to the two drugs compared to treat-
ment with the drugs alone, without BSO (Fig. 3b,c). Thus, the
additional GSH in A549s did not selectively protect these
cells from the chemotherapeutics compared to the HeLa cells.
To determine whether further GSH depletion would result
in an increased sensitivity of A549 cells to piperlongumine
and PEITC, we preincubated A549 cells with 100lMof BSO
for 10 h before the addition of piperlongumine and PEITC.
This pretreatment caused greater depletion of GSH than was
observed for coincubation, resulting in concentrations below
the detection limit of Ellman’s assay. At this level of GSH
depletion, the A549s showed increased sensitivity to pi-
perlongumine and PEITC compared to drug treatment alone
(Fig. 3d,e). It appears that some amount of GSH, however
small compared to the control, is necessary for combating the
toxicity effects of piperlongumine and PEITC. Thus, a way to
increase the potency of the chemotherapeutics to the resistant
A549 cells would be to pretreat the tumors with BSO to
deplete almost all of the GSH, followed by treatment with the
drugs.
The role of oxidative stress generated
by piperlongumine and PEITC
Previous studies of piperlongumine and PEITC used the
fluorescent dye DCFH as an indicator of intracellular oxi-
dative stress, despite its nonspecificity and potential for ar-
tifacts as discussed earlier. The observed increase in DCFH
signal was attributed to the diminishing oxidant scavenging
ability due to the depletion of GSH (39, 49). The studies by
Adams et al. and Zhu et al. appear to contradict that hy-
pothesis; thus, it is necessary to study individual oxidants
produced by these drugs separately to understand the mech-
anisms of action. Since many ROS-based therapies are
thought to interfere with major peroxide-eliminating anti-
oxidants (13), we focused on the role of H2O2 in the toxicity
mechanism of piperlongumine and PEITC using tools that
measure and manipulate the peroxide level. A specific sensor
for H2O2 allows us to determine the amount of this oxidant
that cells generate in response to the compound. An intra-
cellular generator that produces H2O2 allows us to determine
whether quantities generated are sufficient to induce toxicity.
We expressed HyPer, a ratiometric protein-based sensor
with specificity toward H2O2, in the cytoplasm of HeLa cells
exposed to piperlongumine and PEITC. As intracellular
H2O2 increases, the ratio of peaks in the excitation spectrum
at 488 and 415 nm, also known as the HyPer ratio, also in-
creases (3, 11). Incubation of HeLa cells with either drug over
a period of 12.5 h did not result in an increase in the HyPer
ratio, while causing significant growth inhibition effects, with
61% and 38% of live cells remaining for piperlongumine and
PEITC, respectively (Fig. 4a). As a comparison, we coex-
pressed intracellular enzymatic generator for H2O2, DAAO,
with HyPer in the HeLa cells. By adding different concen-
trations of a substrate, D-Ala, we tuned the kinetics of in-
tracellular H2O2 generation by the enzyme, measured via
HyPer ratio changes (black lines, Fig. 4a). To see a 50%
growth inhibition of HeLa cells, we needed a 1.6-fold in-
crease in the ratiometric signal over the 12.5-h period. This
means that to achieve growth inhibition at the same level as
the drug compounds would require H2O2 concentrations
significantly above the detection threshold of the HyPer
sensor. The combination of generator and sensor for H2O2
allows us to conclude that the generation of peroxide alone
cannot cause the observed toxicity of these drugs.
The fact that HyPer’s signal did not provide evidence of
H2O2 elevation leaves the question of whether the amount of
H2O2 produced by piperlongumine and PEITC is below the
detection limit of the probe. Peroxiredoxin II (Prx-2) is an
antioxidant found in the cytoplasm of mammalian cells at
hundreds of micromolar abundance and reacts specifically
with H2O2 at rate constants greater than 10
7 M-1s-1 (21, 29,
31, 32). Compared to HyPer, which exists at submicromolar
concentrations and reacts with H2O2 with second-order rate
constant of 105 M-1s-1 (24, 50), Prx-2 reacts with peroxide
with much higher efficiency, providing greater detection
sensitivity. Upon oxidation by H2O2, a particular cysteine
residue of Prx-2 is oxidized to a sulfenic acid (-SOH), which
can then form a disulfide bond with a nearby thiol group of
another Prx-2 to form a dimer (40, 55). The presence of this
Prx-2 dimer is evidence of H2O2-derived oxidative stress and
has the potential to be a more sensitive peroxide indicator
than HyPer. We treated HeLa and A549 cells with 10 lM
piperlongumine, 10lM PEITC, or 100 lM BSO for 10 h and
used an immunoblot to detect the monomer and the dimer
forms of Prx-2. Treatment with piperlongumine resulted in an
increase in the dimer form of Prx-2 in both HeLa and A549,
while treatment with PEITC or BSO did not cause an increase
in the dimerization of Prx-2 (Fig. 4b,c). We note that this
ROLE OF H2O2 IN ELECTROPHILIC DRUG TOXICITY 927
observed H2O2 increase as a result of piperlongumine treat-
ment is not detected by HyPer. The lack of Prx-2 dimeriza-
tion from BSO and PEITC treatment indicated that the H2O2
increase in response to piperlongumine is not due to gluta-
thione depletion. Comparing the level of Prx-2 dimerization
in HeLa versus A549 cells showed that HeLa cells are much
more susceptible to H2O2 elevation than A549 cells in re-
sponse to piperlongumine. It is thus possible that this dif-
ference afforded the A549 cells an advantage in combating
drug toxicity in comparison with HeLa cells.
To test this hypothesis, we determined whether this small
amount of elevated H2O2 was important for the toxicity of
piperlongumine. By overexpressing catalase in the cyto-
plasm, we provided a means to scavenge the peroxide pro-
duced during piperlongumine treatment. A comparison of
drug toxicity with and without the additional catalase allowed
us to determine whether the elevated H2O2 was an important
part of the drug’s mechanism. We modified the catalase gene
by mutating the peroxisome targeting sequence—KANL of
human catalase to KADL (37). Immunofluorescence staining
and immunoblotting showed that the HeLa cells with this
modified gene construct have increased catalase expression
in the cytoplasm (Supplementary Fig. S2). This modified cell
line, HeLaCat, displayed less Prx-2 dimerization, as well as
less toxicity upon incubation with piperlongumine compared
to the unmodified HeLa cells (Fig. 5), suggesting that the
FIG. 3. Toxicity and glu-
tathione depletion effects of
PL 1 BSO, or PEITC 1
BSO cotreatments. (A) To-
tal GSH concentration of
HeLa, A549 after 10-h incu-
bation with PL or PEITC, and
A549 cells coincubated or
preincubated with BSO (10h).
A549 coincubation and pre-
incubation with BSO, along
with PL or PEITC, cause more
GSH depletion than HeLa cells
treated with PL or PEITC. The
bar graph represents mean –
standard deviation. Every con-
dition has three biological rep-
licates and two technical
replicates each. (B) Coincuba-
tions of A549 cells with 75lM
BSO and 10lM of PL. Cells
remaining after 48 h were
counted and compared to the
control to compute a fraction.
The coincubation did not cause
an increase in the sensitivity of
A549 cells to PL. (C) Coin-
cubations of A549 cells with
75lM BSO and 10lM of
PEITC. Cells remaining after
48h were counted and com-
pared to the control. The coin-
cubation did not cause an
increase in sensitivity of A549
cells to PEITC. (D) Pre-
incubation of A549 cells with
100 lM BSO for 10 h, fol-
lowed by treatment with
10 lM PL for 48 h. (E) Pre-
incubation of A549 cells
with 100 lM BSO for 10 h,
followed by treatment with
10 lM PEITC for 48 h. The
growth inhibition curves
represent mean –95% confi-
dence interval. All coin-
cubation or preincubation
toxicity curves contain two
biological replicates and two
technical replicates each.
*p < 0.05, **p < 0.01.
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FIG. 4. Detection and genera-
tion of hydrogen peroxide in HeLa
and A549 cells treated with PL,
PEITC, and BSO. (A) Measure-
ment of HyPer ratio over a period of
12.5 h for HeLa cells treated with
10lM PL, 10lM PEITC, or virally
transfected with DAAO generator
producing H2O2 with three different
kinetic rates. The percentage of cells
remaining on the dish after 12.5 h
compared to the DMSO control was
determined. Incubation with PL and
PEITC did not cause a rise in the
HyPer ratio, while causing signifi-
cant growth inhibition compared to
the DAAO generators, which did
cause a rise in HyPer ratio. Line
graphs present mean –95% confi-
dence interval from four technical
replicates. (B) Representative blot
measuring oxidized peroxiredoxin-2
as an indicator of peroxide elevation
below the threshold of HyPer de-
tection. HeLa and A549 cells were
incubated with 10lM PL, 10lM
PEITC, or 100lM BSO for a period
of 10 h. An antibody against Prx-2
was used to detect both the dimer
(oxidized) and the monomer form of
Prx-2. Only PL caused a noticeable
increase in Prx-2 dimerization
compared to the DMSO control.
A549 cells show less dimerization in
response to PL than the HeLa cells.
(C) Densitometry data for fold
change over DMSO control in oxi-
dized Prx-2 from treatment with PL,
PEITC, or BSO. The bar graph
represents mean – standard devia-
tion from three biological replicates
performed. *p< 0.05, **p< 0.01.
DAAO, d-amino acid oxidase.
FIG. 5. Effects of catalase over-
expression on HeLa cells treated
with PL. (A) Representative blot
and densitometry measurement of
Prx-2 oxidation for HeLa and He-
LaCat treated with 10lM PL. The
Prx-2 oxidation state of HeLa cells
overexpressing catalase in the cyto-
plasm (HeLaCat) was compared to
HeLa on 10-h incubation with PL.
The bar graph represents mean –
standard deviation from two bio-
logical replicates. (B) Growth inhi-
bition of HeLa cells treated with PL,
PL + TEMPOL, PL + mitoTEMPO,
and HeLaCat treated with PL. Cell
viability was determined after 48 h.
The bar graphs represent mean –
standard deviation from two bio-
logical replicates and two technical
replicates. *p< 0.05, **p< 0.01.
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H2O2 elevation is important to the toxicity mechanism.
To test whether the H2O2 originated from superoxide
dismutation, we pretreated HeLa cells with TEMPOL and
mito-TEMPO before addition of piperlongumine. These
small molecules are superoxide dismutase mimetics that
act as a radical trap for superoxide in the cytoplasm and
mitochondria, respectively (27, 51). Neither TEMPOL nor
mito-TEMPO reduced the piperlongumine-induced Prx-2
dimerization (Supplementary Fig. S3), nor did they improve
the survival of HeLa cells after treatment. Thus, incubation
with the drug led to production of hydrogen peroxide but
not superoxide, and that production conferred some of the
toxic effects.
The observation that low-level H2O2 elevation in pi-
perlongumine treatment is important to drug toxicity is
interesting in comparison with the observation that DAAO-
generated H2O2 at sub-HyPer levels is essentially nontoxic
(Fig. 4a). This implies that H2O2 produced during treatment
with piperlongumine is acting in synergy with the drug to
cause greater toxicity than if the H2O2 is produced indepen-
dently. We measured a major target of H2O2 oxidation, the
thiol groups (-SH) of cysteine residues. Elevated H2O2 can
oxidize the -SH group to sulfenic acid (-SOH), which can
then be followed by protein s-glutathionylation, where GSH
protects the oxidized protein thiols by forming a mixed dis-
ulfide with the -SOH group. The formation of the mixed
disulfide allows the oxidized protein to be repaired by glu-
taredoxin (Grx), which converts the disulfide back to a sulf-
hydryl group (15). Detection of glutathionylated proteins is an
indication of proteins whose thiol groups have been oxidized.
For HeLa cells treated with 10lM piperlongumine, 10lM
PEITC, or 100lM BSO for a period of 10 h, an antibody that
detects protein-GSH complexes was used to visualize intra-
cellular protein oxidation via immunofluorescence. Un-
surprisingly, only piperlongumine treatment showed an
elevation of glutathionylation (Fig. 6a). Thiol oxidation from
piperlongumine treatment was then compared to thiol oxi-
dation from H2O2 generated via DAAO. We found that even
though the DAAO generator produced more intracellular
H2O2 than piperlongumine, at levels well above the detection
limit of HyPer (Fig. 6b), the drug treatment still showed
greater thiol oxidation (Fig. 6c). To understand this higher
thiol oxidation from the drug, we tested whether the reaction
between GSH and the oxidized protein thiol for drug-treated
cells resulted in a disulfide bond. After converting all intra-
cellular sulfhydryl groups of cysteine side chains to -S-S-
CH3 using methyl methanethiosulfonate (MMTS), we used
Grx to reduce GSH-protein mixed disulfides to sulfhydryl
groups (6) and detected the newly reduced groups using
biotinylated maleimide (Fig. 6d). We found that there was no
increased detection of sulfhydryl groups in cells that were
treated with piperlongumine (Fig. 6e), meaning there was
minimal formation of Grx-reducible disulfides. This suggests
that the GSH-protein complexes formed during drug treat-
ment do not contain the typical disulfide bonds formed during
s-glutathionylation. The presence of an irreducible protein-
GSH bond provides a possible hypothesis for how the H2O2
produced by piperlongumine causes enhanced thiol oxidation
and toxicity: proteins oxidized and glutathionylated in the
presence of elevated H2O2 interact synergistically with the
drug to form a unique, irreversibly oxidized protein, the ac-
cumulation of which leads to cell death.
Quantifying the fluorescence signal from protein-GSH
complexes using flow cytometry, we showed that the HeLa
cells displayed more thiol oxidation than the A549 cells in
response to the same piperlongumine treatment (Fig. 6f).
This corroborates our previous data showing less H2O2 ele-
vation in A549 cells compared to HeLa cells in response to
the drug. These results support our hypothesis that A549 cells
were more resistant to piperlongumine than HeLa cells due
an enhanced peroxide scavenging system, which prevented
irreversible protein oxidation by the drug.
The role of Nrf-2 in conferring A549 resistance
to piperlongumine and PEITC
Our investigation so far has shown that A549 cells are much
more resistant to the effects of PEITC and piperlongumine than
HeLa cells. While the GSH level has little effect on resistance
to either compound, we now have evidence suggesting that the
cell’s ability to prevent H2O2 accumulation could be important
for resistance to piperlongumine. To provide a genetic basis for
the increased resistance, we investigated the role of Nrf-2, a
transcription factor that is a master regulator for many pro-
tective functions from oxidative stress inside the cell (8, 46). At
the basal state, Nrf-2 is sequestered and bound to Keap-1 in the
cytoplasm. When an elevation in oxidative stress occurs, the
redox-sensitive Keap-1 is oxidized and undergoes a confor-
mational change, releasing Nrf-2 and allowing it to translocate
into the nucleus, activating the antioxidant response element
(ARE) signaling pathway (22). The products of the ARE
pathway, in turn, modulate oxidative stress, often times by
upregulating important antioxidants related to H2O2. It has
been shown that A549 cells have elevated nuclear Nrf-2, likely
due to the presence of Keap-1 mutations (23, 36, 43, 45).
Therefore, we designed experiments to isolate the effects of the
nuclear Nrf-2 level on the observed cellular responses to
PEITC and piperlongumine treatment. To do so, we used pri-
mary cells from a murine lung tumor model, p53fl/KrasG12D
(10, 52), and two knockoutswere created: Nrf-2 null andKeap-
1 null cells. The three cell lines are hereby known collectively
as the Nrf-2 cell lines. The knockout of Nrf-2 should severely
deplete the nuclear Nrf-2, and the knockout of Keap-1 should
cause a significant increase in the Nrf-2 level, mimicking the
mutations found in A549s. The difference in nuclear Nrf-2
level between these three cell lines was reflected in measure-
ments of intracellular GSH levels, since Nrf-2 regulates GSH
synthesis. The Keap-1 null cells had the highest concentration
of intracellular GSH, at 10 times that of the Nrf-2 null cells
(Supplementary Fig. S4).
When we exposed the Nrf-2 cell lines to both drugs, we
found that the Keap-1 null cells were much more resistant to
the chemotherapeutics than the p53fl/KrasG12D or the Nrf-2
null cells (Fig. 7a,b). In line with this observation, the Keap-1
null cells also showed very little dimerization of Prx-2 during
piperlongumine treatment compared to the other cell lines
(Fig. 7c,d). As a result, the increase in thiol oxidation in
Keap-1 null cells upon piperlongumine treatment was the
least among the three cell lines (Supplementary Table S1).
We can conclude that the increased nuclear Nrf-2 level in the
Keap-1 null cells was important for diminishing the H2O2
elevation caused by piperlongumine treatment, conferring
protection of the cells against the potential toxic effects of
thiol protein oxidation.
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FIG. 6. Protein-GSH detection as evidence of oxidative stress in response to PL and PEITC. (A) Immunofluorescence
detection of protein-GSH conjugate. HeLa cells were incubated for 10 h with 10lM PL, 10lM PEITC, and 100lM BSO,
and then, protein-GSH conjugates were detected using an antibody raised against GSH. Only treatment with PL resulted in an
increase in the level of protein-GSH adducts. The experiment was repeated two times. (B) HyPer measurement of HeLa cells
treated with 10lM PL and HeLa cells virally transfected with DAAO generator with D-ala substrate added. Error bars
represent 95% confidence interval of four technical repeats. (C) Flow cytometry quantification of protein-GSH conjugates for
the PL-treated and DAAO-transfected samples in (B). (D) Schematic of an assay to detect mixed disulfides of protein-GSH
conjugates. The free thiol groups are blocked using MMTS, and then, the mixed disulfide formed by the oxidized protein and
GSH is reduced using Grx. These sulfhydryl groups are detected using biotinylated maleimide. (E) Detection of mixed
disulfides in protein-GSH adducts for HeLa cells treated with PL. PL treatment did not cause a rise in free sulfhydryl level
after reduction via Grx. The experiment was repeated two times. (F) Flow cytometry quantification of protein-GSH adducts
for A549 and HeLa cells treated with 10lM PL. HeLa cells show much greater increase in protein-GSH complexes
compared to the A549 cells. The experiment was repeated two times. Grx, glutaredoxin; MMTS, methyl methanethio-
sulfonate. To see this illustration in color, the reader is referred to the web version of this article at www.liebertonline.com/ars
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Discussion
A better understanding of ROS-based chemotherapeutics
can be achieved by measuring and manipulating the levels of
individual redox molecules inside the cell in a quantitatively
controlled manner. In this study, we focused on PEITC and
piperlongumine, two electrophiles whose toxicity has been
suggested to be related to the observed depletion of GSH and
the observed increase in oxidative stress, as measured by
DCFH, a nonspecific probe. However, a detailed, molecular-
level understanding of the relationship between the toxicity
of these drugs, GSH depletion, and oxidative stress has not
been established. By using tools that specifically measure and
manipulate the levels of GSH and the H2O2 inside the cell, we
were able to further elucidate the roles of these individual
species in the mechanisms of these drugs.
Using the specific GSH synthesis inhibitor, BSO allowed
us to control the GSH level independently of other toxicity
effects of the drugs. Our finding that the GSH depletion alone
cannot cause any toxicity in PEITC or piperlongumine agrees
with previous observations by Zhu et al. and Adams et al.
showing a lack of correlation between the ability to deplete
GSH and cellular toxicity for a sample of small molecules.
The GSH depletion via BSO did not elevate H2O2 as mea-
sured by HyPer or peroxiredoxin dimerization, even though
previous studies have linked it to the elevation in DCFH
signal. The lack of elevation can be attributed to the relative
importance of GSH compared to other faster reacting
FIG. 7. Effect of nuclear NRF-2 level on the cell toxicity and oxidative stress induced by PL and PEITC. Three
model tumor cell lines, p53fl/Kras G12D, p53fl/Kras G12D/Nrf-2-, p53fl/Kras G12D/Keap-1- were created to provide a range of
nuclear NRF-2 levels based on specific mutations found in A549 cells. (A,B) The p53fl/Kras G12D and the knockout cell lines
treated with PL or PEITC concentrations from 0 to 15lM. Number of live cells remaining on the dish after 48 h were
counted and compared to a DMSO-only control after 48 h. The Keap-1 null cell lines were the most resistant to both
compounds. Each point of the growth curve represents mean –95% confidence interval from three biological replicates and
two technical replicates each. (C) Representative blot measuring Prx-2 oxidation via treatment by 10 lM PL for a period of
10 h. The Keap-1 null cell line showed the least amount of oxidation in response to PL treatment, and subsequently, it is the
most resistant to the drug. (D) Densitometry data for the fold change in oxidized Prx-2 over DMSO control in NRF-2 cells
treated with PL. The bar graph represents mean – standard deviation from two biological replicates performed. *p < 0.05,
**p < 0.01.
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antioxidants such as peroxiredoxin and glutathione peroxi-
dase. GSH depletion also did not affect protein glutathiony-
lation during piperlongumine treatment. While the HeLa
cells experience much greater depletion than the A549 cells
in response to incubation with the drug, the abundance of
protein-GSH complexes detected in HeLa cells was still
much greater than the A549 cells. This seemingly contra-
dictory result suggests that the amount of GSH used in re-
actions with oxidized thiols resulting from treatment with
these drugs is negligible compared to the total pool of in-
tracellular GSH. In addition to our finding that GSH depletion
alone is nontoxic, we also found that the amount of depletion
induced by piperlongumine or PEITC is not important for the
increased resistance of A549 cells in comparison with HeLa
cells. This finding resulted from comparing the toxicity to
A549 cells coincubated with BSO and one of the drugs to that
of the HeLa cells incubated with the drug alone. The coin-
cubation depleted the GSH level of A549 cells below that of
HeLa cells incubated with the drug, but it did not decrease the
resistance of A549 cells to the drug. This observation was
surprising because GSH was suggested as a major contrib-
uting factor to chemoresistance in certain tumor cells (42),
but in this case, the cellular GSH level appears unimportant
for sensitivity to piperlongumine and PEITC.
The combination of an intracellular H2O2 sensor and
generator demonstrated a unique approach for understanding
the intracellular oxidative perturbations induced by ROS-
based chemotherapeutics. These tools allowed us to not only
assess whether a specific oxidant is produced but also if the
quantity produced is substantial enough to cause toxicity. In
this study, the HyPer sensor allowed us to conclude that the
amount of peroxide generated by either piperlongumine or
PEITC is below the detection limit of the probe, and the
DAAO generator showed that the H2O2 level below the de-
tection limit is nontoxic. Using Prx-2 dimerization as a more
sensitive way to detect elevated H2O2, we saw that only pi-
perlongumine caused an elevation of H2O2. We investigated
the importance of this H2O2 elevation by eliminating it via
overexpressed catalase in the cytoplasm. We were surprised
to find that the elimination of this low, nontoxic amount of
H2O2 rescued the HeLa cells from toxicity due to pi-
perlongumine treatment, suggesting an essential role for el-
evated H2O2 in the drug’s mechanism of action. Furthermore,
the amount of glutathionylated protein in response to pi-
perlongumine treatment was much higher than that caused by
the peroxide generator DAAO, despite the fact that DAAO
produced more H2O2 than piperlongumine. All of this sug-
gests a toxicity mechanism involving a synergy between the
H2O2 produced and the drug. Molecular tools that enabled
specific measurement and manipulation of intracellular H2O2
levels were critical in achieving an enhanced understanding
of how these redox therapeutics function.
While we cannot confirm the exact mechanism by which
H2O2 and piperlongumine act together to cause enhanced,
irreversible protein oxidation and cell toxicity, our prelimi-
nary investigation into the nature of the protein-GSH bond
formed during piperlongumine treatment provided some
working hypotheses. We found that this bond was not re-
ducible by Grx and atypical of the mixed disulfide bonds
generally formed during glutathionylation, in agreement with
findings from Adams et al. (2). Thus, one possibility is that
the H2O2 produced by piperlongumine causes glutathiony-
lation of thiol proteins, which then interact and form an ir-
reversible covalent bond with piperlongumine. The
irreversible accumulation of oxidized protein gives the drug
its enhanced H2O2 toxicity effect. Testing this hypothesis will
require mass spectrometry to elucidate these protein-GSH
adducts.
One of the lasting challenges of chemotherapy is the var-
iation in drug efficacy against different cell types. A549 cells
belong to a class of nonsmall cell lung carcinomas that typ-
ically have poor prognosis and show resistance to treatment
with chemotherapeutics (12). We found that both pi-
perlongumine and PEITCwere less toxic to A549s than HeLa
cells, but it is unknown what biochemical changes contribute
to this difference in response. In this study, we specifically
examined whether GSH and H2O2 levels played a role in
A549 resistance.We found that A549 resistance to both drugs
is independent of its upregulated GSH level. However, A549
cells were more resistant to H2O2 elevation and subsequent
protein oxidation in response to piperlongumine, suggesting
that these cells may have upregulated antioxidants against
H2O2 that provided the resistance. We manipulated an im-
portant transcription factor involved in antioxidant regula-
tion, NRF-2, which is increased in the A549 cells as a result
of its KEAP-1 mutation. We demonstrated using NRF-2 cell
lines that increased nuclear NRF-2 level, protected cells from
the effects of piperlongumine, and elevated H2O2. This is
perhaps unsurprising since NRF-2 has been shown to be
upregulated in many instances of chemoresistance; cell lines
adapted to increasing concentrations of doxorubicin often
show elevated levels of NRF-2 (42). However, increasing
NRF-2 does not always exert a protective function on the
intracellular oxidant level. A recent study showed that in-
creasing NRF-2 level above a threshold actually amplifies
oxidative stress by induction of KLF9 and causes additional
cellular toxicity, and so, a balance of its pro-oxidant and
antioxidant function has to be considered (58).
Our study showed that the elevation in H2O2 is responsible
for at least part of piperlongumine’s toxicity mechanism, but
we cannot rule out other contributing factors. The increase in
Prx-2 dimerization from incubation with the drug could also
be due to inhibition of thioredoxin, the reduction partner of
Prx-2. There are also alternative ways of causing protein
glutathionylation other than H2O2 oxidation. Free radical
formation on the thiol group followed by reaction with GSH,
and thiol group reaction with oxidized GSH (GSSG) can also
form protein-GSH complexes (7). In addition, we have not
considered the potential role of RNS. Nitric oxide reacts with
thiol proteins in a process called nitrosylation, the product of
which can be an important part of toxicity, and nitrosylated
proteins often convert to glutathionylated proteins by GSH,
adding to the glutathionylation measurement (38). We also
were not able to determine the oxidant relevant to PEITC
mechanism in this study. While originally thought to operate
similarly to piperlongumine, we showed that treatment with
PEITC does not produce H2O2 or superoxide necessary for
toxicity (Supplementary Fig. S5). Recent studies of PEITC
suggest the involvement of RNS (5), but the current reper-
toire of available tools is insufficient to study these molecules
in a controlled manner.
With these caveats, the insights from our study are useful
for future application of both chemotherapeutics, particularly
in combating the chemoresistance of certain tumor cells
ROLE OF H2O2 IN ELECTROPHILIC DRUG TOXICITY 933
through combinational therapy. Even though A549 cells were
robust against GSH depletion from the drugs, there is still
some minimal GSH concentration required for cell survival.
Pretreatment using high concentrations of BSO followed by
PEITC or piperlongumine can make these cells much more
susceptible to the drugs. Furthermore, H2O2 role in the
mechanism of piperlongumine suggests that an effective
strategy of sensitizing A549 cells may be to cotreat the
compound with an inhibitor of H2O2 antioxidants. These
scavenger candidates are likely those upregulated by NRF-2.
More generally, this work provides a demonstration of how to
use specific intracellular sensors and generators to study
particular oxidants, highlighting the need for both tools si-
multaneously to parse the role of a particular species in a
mechanistic study that considers levels. We anticipate that
the resulting enhanced understanding will allow judicious use
and design of ROS-based cancer chemotherapeutics, making
a promising field even more impactful.
Materials and Methods
Materials
Piperlongumine (PL) and BSO, GSH assay kit, and
S-glutathionylation kit were purchased from Cayman Che-
micals. PEITC, DMSO, Triton X-100, D-Ala, Flavin adenine
dinucleotide (FAD), MMTS, and puromycin were purchased
from Sigma. Dulbecco’s modified Eagle’s medium (DMEM)
was purchased from Lonza. Fetal bovine serum (FBS) and
pCAT10 catalase plasmid were purchased from ATCC. Hy-
Per plasmid was obtained from Evrogen. DAAO plasmid was
a gift from Brian Ross (University of Michigan). The lenti-
viral transfer plasmid pLJM-EGFP was a gift from David
Sabatini (Addgene plasmid No. 19319). The HeLa cell line
was a gift from Dane Wittrup (Massachusetts Institute of
Technology). The A549 cell line was a gift from Doug
Lauffenburger (Massachusetts Institute of Technology). The
NRF-2 cell lines, p53fl/KrasG12D, p53fl/Kras G12D/Nrf-2-, and
p53fl/Kras G12D/Keap-1- cell lines were a gift from Tyler
Jacks (Massachusetts Institute of Technology). The HeKFT
cell line and the PAX2 and pMD2.G viral packaging plas-
mids were a gift from Christopher Chen (Boston University).
Cell Tracker Deep Red, Opti-MEM, and Lipofectamine 2000
were purchased from Invitrogen. A primary polyclonal goat
antibody for Prx-2 was purchased from R&D systems. Pri-
mary polyclonal rabbit antibodies for alpha tubulin and
GADPH were purchased from Cell Signaling. A primary
monoclonal mouse antibody (clone no. D8) against protein-
GSH conjugates was purchased from Abcam. Secondary LI-
COR antibodies against goat and rabbit primary antibodies
were purchased from LI-COR Biosciences. Secondary FITC-
labeled antibodies against mouse primary antibody were
purchased from Jackson ImmunoResearch. The same lot for
each antibody was used for all of the experiments.
Cell culture
HeLa, A549, p53fl/Kras G12D, p53fl/Kras G12D/Nrf-2-,
p53fl/Kras G12D/Keap-1- were cultured in DMEM supple-
mented with 10% FBS. The MCF-10A cells were cultured in
DMEM/F12 medium (Invitrogen) supplemented with 5%
horse serum (Invitrogen), 20 ng/ml EGF (Peprotech), 0.5mg/
ml hydrocortisone (Sigma), 100 ng/ml cholera toxin (Sigma),
and 10 lg/ml insulin (Sigma). The cultures were maintained
in a 37C humidified incubator in the presence of 5% CO2.
Medium was changed every 3 days and cells were passaged
every 5–6 days. HeLa cells virally transfected with plasmids
containing HyPer, catalase, and DAAO were maintained in
the same DMEM containing 2 lg/ml of puromycin.
Molecular cloning for HyPer, catalase, and DAAO
The coding sequence for HyPer (1.5 kb) and DAAO
(1.2 kb) was amplified and reinserted in the lentiviral transfer
vector pLJM-EGFP at cloning sites Nhe1 and BamH1, re-
moving the EGFP. The relevant coding sequence of human
catalase (1.6 kb) was amplified from the pCAT10 vector with
a point mutation in the reverse primer, changing the penul-
timate amino acid from asparagine (N) to aspartic acid (D).
The primers used to amplify the sequence were 5¢ primer:
AAAA GCTAGC GCA GTG TTC CGC ACA GCA AAC
and 3¢ primer: AAAA GGCGCGCC TCA CAG ATC TGC
CTT CTC CCT TGC (the underlined part being the point
mutation), and inserted between the Nhe1 and Asc1 sites of
the pLJM vector. Constructs were verified by sequencing.
Lentiviral transfection of cells with genes encoding
HyPer, catalase, and DAAO
HEK FT cells were seeded at 7.5 · 105 cells/35-mm well
and grown for 2 days until 90% confluence. The pLJM
transfer vector with the appropriate gene insert was co-
transfected with the packaging plasmids PAX2 and pMD2.G
at a 3:2:1 ratio for a total of 5 lg of plasmid and 10lg of
Lipofectamine 2000 for a period of 18 h in Opti-MEM.
Subsequently, 1ml of DMEM supplemented with 10% FBS
was used to replace the transfection medium. This medium
containing lentiviruses was collected every 24 h for a period
of 2 days. The mediumwas centrifuged at 500 g for 5min and
the supernatant was collected. One milliliter of the superna-
tant, along with 6 lg/ml of polybrene, was then added to an
80–90% confluent 35-mm well of HeLa cells. Three days
postinfection, the medium containing 5 lg/ml of puromycin
was used for selection of HeLa cells containing the plasmid
for a period of 10 days.
Growth inhibition assay
HeLa and A549 cells were seeded at 1.5 · 105 cells/well in
a 12-well plate the night before drug addition. The MCF-10A
cells were seeded at 0.75 · 105 cells/well in a 12-well plate 2
days before drug addition. All of the cell lines have similar
cell count at the start of the drug treatment. One milliliter of
appropriate media for each cell line containing the chemo-
therapeutic was added to each well and incubated for a period
of 48 h. Afterward, the remaining live cells on the dish were
trypsinized and quantified using the Beckman Coulter Vi-
Cell Counter, which detects exclusion of trypan blue. The
fraction of live cells remaining was calculated by dividing
the number of live cells for each experimental condition by
the number of live cells in the control case with DMSO only,
48 h postdrug addition.
Total GSH measurement
Cells were seeded at 3.5 · 105 cells/well in a six-well dish.
The next day, 2.5ml of DMEM supplemented with 10% FBS
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containing the appropriate chemotherapeutic was added to
each well and incubated for a period of 10 h. Afterward, the
cells were trypsinized and lysed with 100lL of 1% triton X-
100 for 20min on ice, followed by 10min of centrifugation at
12,000 g. Proteins in the supernatant were precipitated using
an equal volume of 0.1 g/ml of metaphosphoric acid. Cen-
trifugation at 12,000 g separated the liquid from the precip-
itate. The pH was readjusted by adding 4M triethanolamine
at 1:20 dilution to the supernatant. Both oxidized and reduced
glutathione were measured by using glutathione reductase to
reduce the GSSG, followed by reaction with DTNB (Ell-
man’s Reagent) as dictated by the Glutathione Quantification
Kit from Cayman Chemicals.
Using DAAO enzyme for controlled
peroxide production
HeLa cells cotransfected with HyPer and DAAO plasmids
were seeded at 3.5· 105 cells/well on a six-well plate. The
substrate for the DAAO enzyme, D-Ala, was added at 0–
20mM concentrations to the 2ml of extracellular medium
(10% FBS +DMEM), along with the cofactor substrate FAD at
5lM. Four to five images per well of the cells were taken with
the HyPer wavelengths every 30min for a period of 12.5 h.
Quantification of HyPer’s fluorescent signal
Fluorescent images of all cells expressing HyPer were
captured using an Olympus wide-field fluorescence micro-
scope (IX81) on a 10· Olympus objective. Samples were
excited using a Prior Lumen2000 lamp at wavelengths 415/
30 nm and 488/25 nm light and emission was recorded at 525/
40 nm, with lamp intensity set at 10% and an exposure time of
300ms. Four to five fields of view were captured per condi-
tion, and the images were exported to ImageJ for post-
processing. All images were background subtracted using the
rolling ball algorithm with radius of 200 pixels, and then, the
mean pixel intensity for each image was measured (19). The
HyPer ratio for each field of view was calculated by dividing
the mean pixel intensity at 488 nm by the mean pixel intensity
at 415 nm. The baseline HyPer ratio under these conditions is
0.5, and the maximum ratio for the probe is 0.9.
Immunoblotting for Prx-2 oxidation
Cells were seeded at 3.5· 105 cells per well in a six-well
plate. Thewells were treated with 2.5ml of 10lMPL, PEITC,
or 100lM of BSO for a period of 10 h. After treatment, the
cells were trypsinized, washed once with phosphate-buffered
saline (PBS), followed by resuspension in 2ml of 100mM
MMTS to convert sulfhydryl groups to -S-CH3. to prevent
oxidation artifacts (44). The MMTS cell suspension was
placed on ice for 20min, followed by two more PBS washes.
The cell pellet was lysed using 100ll of 1% Triton X-100,
spun at 12,000 g for 10min, and the supernatant cell lysate
was collected. To immunoblot for the monomer and dimer
form of Prx-2, we ran a nonreducing tris-tricine gel. After
transfer, the blot was incubated overnight in the goat anti-Prx2
primary antibody (1:1000 in PBS-blocking buffer-Tween20)
at 4C. The next day, the LI-COR anti-goat secondary anti-
body IR 688 was added at 1:10,000 dilution and incubated for
1 h. Blots are visualized using an Odyssey CLx Infrared
Imaging System (Koch Institute, Cambridge, MA).
Detection of protein-GSH conjugation
By immunofluorescence: HeLa cells seeded at 1.0 · 104
cells/well in a 24-well plate were incubated for 10 h with
10lM PL, PEITC, or 100lM of BSO. After incubation, the
cells were fixed in plate with 4% paraformaldehyde for
30min, washed three times with PBS, and followed by per-
meabilization with 0.5% triton X-100 in PBS (PBS with 0.5%
Triton x-100 [PBST]) for 30min. The cells were then blocked
for 30min in PBST +2% BSA, and then, the primary mouse
antibody against glutathione protein conjugates at 1:200 di-
lution in PBST +2% BSA overnight at 4C. After three wa-
shes with PBST, the secondary anti-mouse FITC antibody
was incubated at 1:250 dilution in PBST +2% BSA. The
images were acquired using a Nikon x81 epifluorescence
microscope at 10% lamp intensity and 200ms exposure.
By flow cytometry: HeLa and A549 cells seeded at 2 · 105
cells/well in a six-well plate were incubated for 10 h with
10lMPL, or DMSO control. After incubation, the cells were
trypsinized, washed with PBS, and resuspended in 4%
paraformaldehyde for 30min. After fixation and washing, the
cells were permeabilized with 0.5% triton X-100 for 30min,
and then blocked with 2% BSA for an hour on a rocker. The
cell pellets were resuspended in 100 ll of 1:100 primary
mouse antibody and rocked for 2 h at room temperature. After
washes, cells were resuspended in a secondary anti-mouse
FITC antibody solution (1:100 dilution) and incubated for
30min on ice. The labeled cells were analyzed using a Becton
Dickinson LSR II (Becton Dickinson).
Immunofluorescence quantification
of S-glutathionylation
HeLa cells were seeded at 7500 cells/well in a 24-well
plate, and then treated for 10 h with 10 lM PL, or DMSO
control. After incubation, the cells were fixed on the dish with
4% paraformaldehyde for 30min, followed by PBS washes.
Following fixation, cells were labeled with Cell Tracker Deep
Red for 1 h at RT. Cells were permeabilized and protein-free
thiols were blocked with 100mMMMTS. The reduction and
detection steps were carried out according to the instructions
provided with the S-Glutathionylation Kit from Cayman
Chemicals. Eight images were taken per condition (N = 200)
using a Nikon x81 epifluorescence microscope with an FITC
filter set (biotinylated reduced thiol groups) and a Cy5 filter
set (cell tracker label) using 400ms exposure, 10% lamp
intensity. Using a pipeline we built in Cell Profiler (Broad
Institute, Cambridge, MA) (4), the Cell Tracker Red images
were used to determine the outline of the cells, create a mask
that was then superimposed onto the FITC images, and the
total pixel intensity per cell was determined.
Statistical analysis
Data for toxicity curves are expressed in mean –95%
confidence interval and compared between different cell
types and conditions. Data for all bar graphs are expressed in
mean – standard deviation among separate experiments. The
statistical differences between pairs of bar graph groups are
analyzed using Student’s t-test with p-values <0.05 consid-
ered significant. *Indicates p < 0.05 and **indicates p < 0.01.
Information about replicate numbers for specific experiments
can be found in the legend for each figure.
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Abbreviations Used
ARE¼ antioxidant response element
BSO¼ buthionine sulfoximine
DAAO¼d-amino acid oxidase
D-Ala¼d-alanine
DCFH¼ dichlorofluorescein
DMEM¼Dulbecco’s modified Eagle’s medium
DTNB¼Ellman’s reagent
FAD¼flavin adenine dinucleotide
FBS¼ fetal bovine serum
Grx¼ glutaredoxin
GSH¼ glutathione
HeLaCat¼HeLa cells virally transfect
with cytoplasmic-targeted catalase
MMTS¼methyl methanethiosulfonate
NRF-2¼ nuclear factor erythroid 2-related factor 2
PBS¼ phosphate-buffered saline
PBST¼ PBS with 0.5% Triton x-100
PEITC¼ phenethyl isothiocyanate
PL¼ piperlongumine
Prx-2¼ peroxiredoxin-2
RNS¼ reactive nitrogen species
ROS¼ reactive oxidative species
-SH¼ sulfhydryl group
-SOH¼ sulfenic acid
938 HUANG ET AL.
